Canada Life
CALA

Canada Life’s Calithera Biosciences, Inc CALA Stock Holding History

Canada Life’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-287
Closed -$14K – 2595
2021
Q1 		$14K Hold
287
– – ﹤0.01% 2545
2020
Q4 		$28K Hold
287
– – ﹤0.01% 2482
2020
Q3 		$20K Hold
287
– – ﹤0.01% 2449
2020
Q2 		$30K Buy
+287
New +$34.1K ﹤0.01% 2404
2018
Q2 		– Sell
-165
Closed -$21K – 2735
2018
Q1 		$21K Hold
165
– – ﹤0.01% 2501
2017
Q4 		$27K Buy
+165
New +$42.3K ﹤0.01% 2471

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Canada Life's CALA Position: Q2 2021 in Review

Canada Life sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 287 shares — an estimated $14K sold.

Canada Life first reported a position in CALA in Q4 2017 and held it in 6 quarters. The position peaked at $30K in Q2 2020. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • Canada Life reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • Canada Life sold 287 Calithera Biosciences, Inc shares in Q2 2021, an estimated $14K.
  • Canada Life first reported a position in Calithera Biosciences, Inc in Q4 2017 and held it in 6 quarters.
  • Canada Life's Calithera Biosciences, Inc position peaked at $30K in Q2 2020.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Canada Life's 13F filing for Q2 2021, filed 11 Aug 2021.